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Background: Engineered nanoparticles (NP) are being developed for inhaled drug delivery. This route is non-invasive
and the major target; alveolar epithelium provides a large surface area for drug administration and absorption, without
first pass metabolism. Understanding the interaction between NPs and target cells is crucial for safe and effective
NP-based drug delivery. We explored the differential effect of neutral, cationic and anionic polystyrene latex NPs
on the target cells of the human alveolus, using primary human alveolar macrophages (MAC) and primary human
alveolar type 2 (AT2) epithelial cells and a unique human alveolar epithelial type I-like cell (TT1). We hypothesized that
the bioreactivity of the NPs would relate to their surface chemistry, charge and size as well as the functional role of
their interacting cells in vivo.
Methods: Amine- (ANP) and carboxyl- surface modified (CNP) and unmodified (UNP) polystyrene NPs, 50 and 100 nm
in diameter, were studied. Cells were exposed to 1–100 μg/ml (1.25-125 μg/cm2; 0 μg/ml control) NP for 4 and 24 h
at 37 °C with or without the antioxidant, N-acetyl cysteine (NAC). Cells were assessed for cell viability, reactive oxygen
species (ROS), oxidised glutathione (GSSG/GSH ratio), mitochondrial integrity, cell morphology and particle uptake
(using electron microscopy and laser scanning confocal microscopy).
Results: ANP-induced cell death occurred in all cell types, inducing increased oxidative stress, mitochondrial disruption
and release of cytochrome C, indicating apoptotic cell death. UNP and CNP exhibited little cytotoxicity or mitochondrial
damage, although they induced ROS in AT2 and MACs. Addition of NAC reduced epithelial cell ROS, but not MAC ROS,
for up to 4 h. TT1 and MAC cells internalised all NP formats, whereas only a small fraction of AT2 cells internalized ANP
(not UNP or CNP). TT1 cells were the most resistant to the effects of UNP and CNP.
Conclusion: ANP induced marked oxidative damage and cell death via apoptosis in all cell types, while UNP and CNP
exhibited low cytotoxicity via oxidative stress. MAC and TT1 cell models show strong particle-internalization compared
to the AT2 cell model, reflecting their cell function in vivo. The 50 nm NPs induced a higher bioreactivity in epithelial
cells, whereas the 100 nm NPs show a stronger effect on phagocytic cells.
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The emergence of nanotechnology and nanomedicine is
of increasing interest, particularly for local and systemic
treatment via inhaled drug delivery to the lung [1–4]; a
range of NP-based agents have been developed to im-
prove therapeutic and diagnostic efficiency, and to
minimize adverse effects [5–8]. These products have
been studied in vivo [9–11], and also in clinical trials
and some have reached the clinic for the treatment of
cancer, diabetes, and other lung diseases [6, 8, 12, 13]
with varying degrees of success, related to a range of fac-
tors, including the unique physicochemical structure of
each type of NP and its bioreactivity. Administration of
drugs via the lung can be performed non-invasively of-
fering several advantages: the thin alveolar epithelial-
endothelial barrier provides a large surface area with ex-
tensive vascularisation for effective drug absorption, low
endogenous biotransformation activity and the drug will
escape first pass metabolism in the liver [2, 3, 14].
Despite the increased use of inhalation of NPs for drug
delivery [3, 15], little is known of the impact of engi-
neered NPs on the alveolar epithelial barrier [7, 16]. It is
suggested that deposition of both anthropogenic and
engineered nano-sized particles could cause lung inflam-
mation via oxidative stress, relating to their physico-
chemical properties [17, 18].
The alveolar respiratory unit is composed of alveolar
type I (AT1) and type II (AT2) epithelial cells and alveo-
lar macrophages (MAC). AT1 cells share a fused base-
ment membrane with capillary endothelium to form a
thin wall at the gas-blood barrier that facilitates gas ex-
change. AT2 cells secrete a range of molecules involved
in lung defence and homeostasis, including lung surfac-
tant which maintains reduced surface tension to prevent
alveolar collapse; AT2 cells also proliferate and differen-
tiate into AT1 cells to replace injured AT1 cells and have
recently been described as an alveolar epithelial stem cell
[19]. Alveolar macrophages (MAC) are responsible for
removing foreign particles and other debris from the al-
veoli including allergens, microorganisms and inorganic
particulate matter. All three cell types release pro-
inflammatory mediators and we have demonstrated that
interplay between these cells plays a vital role in regulat-
ing the pulmonary immune response [20, 21].
Regarding efficacious use of inhaled nano-drugs, the
drug must be delivered intracellularly, involving NP up-
take into and possibly translocation across the cell. For
others, appropriate reactivity and delivery at the cell sur-
face membrane is the aim [9, 22, 23]. However, it is im-
portant to appreciate the exact cellular responses, to
avoid unwanted effects such as cytotoxicity, inflamma-
tion and tissue injury and therefore to optimise treat-
ment. We hypothesised that NP size and surface
modification would crucially impact on these processes,and the induction of oxidative stress would be a bio-
marker of unwanted effects of nano-drugs. Therefore in
this novel study, we have examined the effect of nano-
size and surface chemistry/charge of model polystyrene
latex NPs on oxidative stress and cellular toxicity with
immortalised human AT1 (TT1), primary human AT2
and MAC cells, representing the first cellular targets of
inhaled nano-drugs in the human respiratory unit.
There is no standard in vitro model of the alveolar epi-
thelial barrier to study drug transport, pharmacokinetics
and bioreactivity; for example many in vitro studies util-
ise the A549 adenocarcinoma cell line as a substitute for
primary human alveolar epithelial type II cells [24–26],
whilst others utilise the Calu-3 human bronchial epithe-
lial cell line, also derived from a pulmonary adenocarcin-
oma, to investigate changes in barrier function of large
airway epithelium [27, 28]. We believe it is also relevant
to use cell lines derived from normal lung cells and pri-
mary cells [21]. Furthermore, it is not possible to isolate
sufficient primary human alveolar type 1 epithelial cells
(many of which do not survive the procedure), and there
is no commercially available source, thus, we have gener-
ated a unique immortal human AT1-like cell line (TT1)
[29] from their progenitor cells, primary human AT2
cells [30]. In parallel, we study freshly prepared human
lung AT2 cells [30] and MACs, from the same pieces of
human lung tissue with normal appearance, removed
during surgery for lung cancer. We have used these
models in the following studies of the interaction of 50
and 100 nm polystyrene latex NPs, unmodified (UNP)
and also surface-modified with amine (ANP) and carb-
oxyl groups (CNP).
Results
Assessment of particle size and surface charge of latex
nanoparticles
The interaction of nanosized-materials with body fluids
is an early event; we and others have shown that com-
ponents of extracellular fluids adsorb to the particles
[31–33]. Importantly, we recently showed that polystyr-
ene latex nanoparticles adsorb components of the tissue
culture medium [31], which is likely to alter the surface
charge and format of the NPs presented to the cells.
Here the hydrodynamic diameter and surface charge
density of each surface group (Table 1) in distilled water
(DW) and in tissue culture medium (DCCM1 and
RPMI) were measured. All NPs were monodisperse in
DW but formed small agglomerates in DCCM1 and
RPMI (Table 1), as indicated by the increase in average
hydrodynamic diameters and polydispersity index values
(PDI), likely reflecting adsorption of proteins and other
components of the medium [31]. The surface charge
densities (measured as zeta potential; Table 1) of the
NPs also depended on the dispersing medium; the
Table 1 Surface chemistry, hydrodynamic diameter, and surface charge density of unmodified- (UNP), carboxyl-modified (CNP) and
amine-modified (ANP) latex nanoparticles in distilled water (DW) and tissue culture medium (DCCM1 and RPMI)
Particles Surface functional group Average diameter nm(±SD) Polydispersity index Zeta potential mv(±SD)
The data are presented as mean ± standard deviation (SD), n = 3β
βNanoparticles were suspended in distilled water and DCCM1 or RPMI at a concentration of 10 μg/ml and bath sonicated for 2 min before measurement
(see methods)
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UNP (−50.5 ± 2.56 mV) show strong positive and nega-
tive surface charge densities in DW relating to their sur-
face functional group (−OH for UNP,-COOH for CNP
and –NH2 for ANP; Table 1), but their surface charge
became very similarly moderately negative, regardless of
their original charge, in DCCM1, as follows: ANP
(−11.4 ± 0.90 mV), CNP (−13.1 ± 0.89 mV) and UNP
(−15.5 ± 0.81 mV) and in RPMI ANP (−35.2 ± 0.56 mV),
CNP (−33.0 ± 0.97 mV) and UNP (−14.8 ± 2.10 mV).
Effect of size and surface chemistry on cell viability
Previously we reported that 50 nm ANP induced cell
death and pore formation at the cell membrane of TT1
cells, together with increased release of IL-6 and IL-8
and activation of caspase 3/7 and 9 [31]. Here, we fur-
ther investigated the effect of NPs on their ability to in-
duce intracellular reactive oxygen species (ROS) as this
might impact on cell viability and bioreactivity. The
50 nm ANPs were reported to be more toxic than
100 nm ANPs; 50 nm ANPs were also more toxic than
50 nm UNPs and CNPs after 24 h exposure [31]. In this
study, we showed that following 4 h exposure, there was
only a slight toxic effect of ANP on TT1 at concentra-
tions between 50-100 μg/ml (Additional file 1: Figure
S1). We also investigated if the same response profile
would occur with AT2 and MACs using a similar NP
concentration range and 24 hour exposure. The cytotox-
icity of 50 and 100 nm NPs against TT1, AT2 cells and
MACs showed a similar pattern of response, whereANPs, but not UNPs or CNPs, were very cytotoxic
(Fig. 1a-f ). The 50 nm ANPs were toxic even at the
lower concentrations of 10 and 25 μg/ml (t = 24 h,
n = 6), inducing approximately 20 % cell death, com-
pared to <10 % cell death for the same concentrations of
50 nm UNP and CNP and 100 nm ANPs. ANPs, 50 μg/
ml, induced approximately 50 % cell death in MACs,
compared to 30−35 % cell death (t = 24 h, n = 6) in the
epithelial cells, although the highest concentration,
100 μg/ml ANP caused a similar degree of cell death in
all cell types (~60 %; Fig. 1b, d and f). At the highest
concentration of 100 nm NPs there was approximately
45−50 % AT2 and MAC cell death (Fig. 1d and f), al-
though TT1 cells exhibited less than 20 % cell death at
this concentration (Fig. 1b). We suspected that oxidative
stress might associate with ANP toxicity, and therefore,
the addition of antioxidant N-acetyl-cysteine (NAC,
10 mM) would reduce cell death following ANP expos-
ure. When TT1, AT2 cells and MACs were exposed to
the 50 nm NPs (t = 24 h) in the presence of NAC (Fig. 1g-
i, Additional file 1: Figure S2), there was little effect on the
UNP- or CNP-treated cells, as expected due to little effect
of the NPs alone (Additional file 1: Figure S2). Regarding
the marked cell death induced by 50 nm ANP, there was no
improvement in cell viability of TT1 cells (Fig. 1g). In
MACs, NAC had only a small protective effect on cell
death at 10 μg/ml ANP (Fig. 1i). However, in AT2 cells
(Fig. 1h), NAC prevented the effects of 10 and 25 μg/ml
50 nm ANP, and caused a small improvement in the effect
of 100 μg/ml ANP on AT2 cell viability.
Fig. 1 Viability of TT1, AT2 and MAC following 24 h exposure to 50 nm and 100 nm polystyrene nanoparticles. 50 nm ANPs, at 50-100 μg/ml,
caused significant cell death in all cell types (a, c, e). 100 nm ANP, 50 and 100 μg/ml, caused significant cell death in AT2 and MAC but not TT1
cells (b, d, f). Addition of antioxidant N-acetylcysteine (NAC), 10 mM, did not prevent TT1 cell death (g), whereas NAC protected AT2 and MAC
from the effects of low concentrations of ANPs (h-i). UNP and CNP had no effect on cell viability. *p < 0.05, **p < 0.001 and n = 3 TT1 replicates
and n = 6 subject samples for AT2 and MAC
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the lactate dehydrogenase (LDH) assay to examine
membrane integrity (n = 6, t = 4 and 24 h; Additional file
1: Figure S3–S4). We previously observed a marked re-
lease of LDH by TT1 cells exposed to 50 nm ANP (but
not UNP or CNP) which paralleled the formation of
“holes” within the cell membrane [31]. AT2 cells ex-
posed to all types of 50 and 100 nm ANPs released LDH
(Additional file 1: Figure S3); the most significant release
of LDH was on exposure to 50 nm CNPs, ANPs and
100 nm ANPs (p < 0.001, n = 6). The release of LDH was
time and NP concentration dependent; the smaller NPs
induced the highest LDH. At the higher concentrations
of 50 nm ANPs (25-100 μg/ml), there was up to 60 %
LHD release, which mirrored MTT estimation of AT2
cell death (Fig. 1c-d). In contrast, in the MAC studies,
the 100 nm NPs had the greatest effect on LDH release
compared to 50 nm NPs following 24 h exposure (p <
0.001, n = 6; Additional file 1: Figure S4), which was alsoconcentration and time dependent. ANPs exhibited
higher toxicity than UNPs and CNPs, and there was
marked release of LDH at the higher concentrations of
100 nm ANPs (25-100 μg/ml) causing up to 75 % LDH
release following 24 h exposure, in parallel to the MTT
measure of cell death (Fig. 1e and f). Interestingly, LDH
did not exactly mirror MTT measure of cell death for
MAC experiments exposed to 100 nm UNP and CNP.
Effect of nanoparticles on the release of inflammatory
mediators, IL-6 and IL-8
Following 24 h exposure, all types of NPs activated sig-
nificant increased release of IL-6 and IL-8 (p < 0.001,
n = 6) by AT2 cells and MAC (Additional file 1: Figure S5).
The increase in IL-6 release by AT2 was much the same
regardless of NP concentration or surface modification.
This may in part reflect the similarity in surface charge
density (zeta potential) between the NPs, which was simi-
lar in DCCM1 medium, between −11.4 and −15.5 mV
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creasing NP concentration. The marked increase at
even low NP concentrations may be due to induction
of the maximal IL-6 response. Neither is it clear why
there are no differences between the magnitude of the
effect of 50 and 100 nm NPs, considering the marked
increase in NP numbers and surface area/unit weight
of the 50 nm NPs, as discussed previously [31]. In
contrast, an effect of particle size was observed for re-
lease of IL-8 (Additional file 1: Figure S5d-f ); 50 nm
NPs induced a significantly greater release of IL-8
than that of the 100 nm NPs. However, as for IL-6,
there was no effect of increasing NP concentration on
AT2 cell IL-8 release. In contrast, for MACs (Add-
itional file 1: Figure S6) increased release of IL-6 and
IL-8 correlated with NP concentration. Surface chem-
istry was important (p < 0.001, n = 6); ANPs and UNPs
induced the greatest, similar levels of IL-6 and IL-8 re-
lease, compared to CNPs. Again, there was little effect
of NP size on IL-6 release, whereas 100 nm UNP and
CNP induced more IL-8 release than did the 50 nm
NPs. We previously reported that all three types of
50 nm NPs stimulated a concentration-dependent re-
lease of IL-6 and IL-8 by TT1 cells [31]. Others have
shown that polystyrene latex stimulated IL-8 release
by A549 cells; the smallest, 60 nm NPs, caused the
highest release compared to 200 and 500 nm NPs [34].
Prietl et al. reported a similar pattern of IL-8 release by
macrophages exposed to 20, 500 and 1000 nm carboxyl
modified latex particles [35].
Effect of nanoparticles on the activation of intracellular
reactive oxygen species (ROS)
We used 2′, 7′-dichlorodihydrofluorescein diacetate
(H2-DCFDA; to detect peroxide and singlet oxygen) and
dihydroethidium (DHE; to detect superoxide radicals)
dyes to monitor intracellular ROS. Both dyes indicated a
similar pattern of ROS induction within TT1 cells; how-
ever, only DHE effectively detected ROS in AT2 and
MAC, indicating differences in ROS production between
the cells. ANPs (50 nm) significantly initiated ROS
production in TT1 cells in a concentration dependent
manner at 4 h, when there was no cell death (p < 0.001,
n = 3; Additional file 1: Figure S1, S7a-d, s). The ROS de-
tected by H2-DCFDA remained over 24 h, when there
was significant cell death, as can be seen by cell loss in
Additional file 1: Figure S7f. UNPs did not initiate ROS
detected by H2-DCFDA in TT1, whereas CNPs took up
to 24 h to induce ROS (Additional file 1: Figure S7).
ANPs induced massive production of ROS (detected by
DHE and H2-DCFDA) in TT1 cells, p < 0.001, n = 3, at
both 4 and 24 h (Fig. 2d, aa. Additional file 1: Figure
S7a-d, f, s-t). Although UNPs and CNPs induced TT1
ROS, it was much lower than that observed with ANP(Fig. 2b and c, aa; Additional file 1: Figure S7g-h, t). In
contrast, all types of NPs initiated significant production
of ROS (detected by DHE) in AT2 (p < 0.001, n = 3,
Fig. 2j, k, l and ab) and MACs (Fig. 2r, s, t and ac), which
in AT2 cells was concentration-dependent (Additional
file 1: Figure S7i-r, u). This effect was completely elimi-
nated in AT2 cells by co-incubating the antioxidant N-
acetyl-cysteine (10 mM) with the NPs (Fig. 2n, o, p and
ab), which also prevented ROS formation in TT1 cells
exposed to UNP and CNP (Fig. 2f- g, aa), though only
partially eliminated ROS in TT1 cells exposed to ANP
(Fig. 2h, aa). In contrast, NAC had little effect when added
to NP-exposed MACs, regardless of surface modification
(Fig. 2v-x, ac). Although the induction of oxidative stress
was observed following NP exposure to all types of NPs,
differences were observed in the magnitude and profile of
ROS activity relating to both surface modification and cell
type (Fig. 2aa, ab, ac). Although the cells were seeded at the
same density, in the case of the primary MACs not all the
seeded cells adhered to the plate and the final number of
MACs was less than those for AT2 and TT1 cells. This re-
sulted in an overall reduction in the measured intensity of
ROS in MAC (Fig. 2ac) compared with TT1 and AT2 cells
(Fig. 2aa and ab).
Effect of nanoparticles on glutathione flux
As we have limited numbers of primary AT2 and MAC
cells, we used TT1 cells as a model to study the effect of
oxidative stress on glutathione flux. Cellular glutathione
levels (GSH and GSSG) were measured in TT1 cells at 1
and 4 h after 50 nm NP exposure (Fig. 3a, b). After 1 h,
the GSSG/GSH ratio (indicating the ratio of oxidised
GSSG to reduced GSH) was increased, 2-3-fold above non-
treated control cells, for all types of NPs (at concentrations
of 50 and 100 μg/ml) reflecting oxidative stress (Fig. 3a-b).
By 4 h (Fig. 3b), control (baseline) TT1 cell GSSG/GSH ra-
tio had increased above that observed at 1 h. There was a
further, significant increase in the GSSG/GSH ratio follow-
ing ANP exposure, even at the lowest concentration of
1 μg/ml (1.5-fold control; p < 0.05, n = 3), which increased
in a concentration dependent manner, reaching >6-fold that
of unexposed cells (p < 0.001, n = 3) at 50 μg/ml ANP; this
effect was not observed with UNP or CNP. Co-incubation
of NPs with NAC for 4 h prevented the reduction of total
cellular glutathione (GSH and GSSG combined; Fig. 3c).
The highly significant fall (down to ~10 % of control, p <
0.001, n = 3) in glutathione following exposure to 50 nm
ANPs could be markedly prevented by NAC treatment
(down to ~67 % of control). A similar trend was also ob-
served in TT1 cells exposed to 100 nm NPs, although the
effect of all three NPs on increased GSSG/GSH ratio at 1 h
was more noticeable than that seen following exposure to
the 50 nm NPs at the same time interval (Fig. 3d). Remark-
ably, this effect disappeared for UNP and CNP at 4 h, but
Fig. 2 Induction of reactive oxygen species by 50 nm UNP, CNP and ANP in the absence and presence of antioxidant N-acetylcysteine. Cells were
exposed to 25 μg/ml of 50 nm NPs for 4 h, alone (a-d, i-l, q-t) and in the presence (e-h, m-p, u-x) of 10 mM NAC. All types of NPs induced significant
ROS production in AT2 (i-l) and MAC (q-t), whereas TT1 cells (a-d) were most susceptible to ANP. NAC treatment significantly prevented NP-induced ROS
in epithelial cells (aa, e-h, ab, m-p), but not macrophages (ac, u-x). ROS were measured in live cells and data are presented as mean fluorescence intensity
(MFI) ± SD (n= 3 TT1 replicates and 6 subject samples for AT2 and MAC) in aa-ac *p< 0.05; **p< 0.001
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(Fig. 3e). NAC prevented the reduction of cellular glutathi-
one activated by 100 nm NPs (Fig. 3f) to a very similar ex-
tent to that seen with 50 nm NPs.
Effect of nanoparticles on mitochondrial function and
structure
Mitochondrial membrane potential and mitochondrial
structure of TT1 cells following NP exposure (Fig. 4–5)
were observed to compare with changes in ROS produc-
tion, using MitoTracker® fluorescent probe, confocal mi-
croscopy and transmission electron microscopy (TEM).
The MitoTracker® probe reflected mitochondrial mem-
brane potential of the intact mitochondria; a significant
decrease in mean fluorescence intensity (MFI), indicat-
ing reduction of mitochondrial membrane potential in
all cell types exposed to 50 nm ANPs (t = 4 h, Fig. 4a-c;
p < 0.001, n = 3 replicates TT1 and 6 subject samplesAT2 and MAC). This was accompanied by mitochon-
drial swelling and disruption of the mitochondrial net-
work in ANP-exposed cells (Fig. 4–5), as shown by TEM
(Fig. 4, n = 60 observed cells) and confocal microscopy
(Fig. 5, n = 45 observed cells). Mitochondrial swelling is
a pathology of mitochondria indicated by an increase in
volume of mitochondria due to the fluid influx as a re-
sult of altered mitochondrial membrane potential. The
enlarged size of the mitochondria can be seen at the
same magnification (same scale bar) as we show here in
Fig. 4k, n and o, in comparison to the control cells in
Fig. 4d, h and l. The structure of cristae collapse during
the swelling process cannot be detected by the osmium
contrast agent when using TEM. We also investigated
changes in mitochondrial structure at the lower NP con-
centration range (1-25 μg/ml) using transmission elec-
tron microscopy (TEM) and did not see a difference
compared to non-treated cells (data not shown). In the
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where each mitochondrion is linked to another as seen
in control cells in Fig. 5 (the connected green fluores-
cent feature, control panel). Disconnection of the green
fluorescent feature indicated the disconnected mito-
chondria within the network (change from green con-
nect line to green dot), as seen following exposure to
ANP (ANP, green fluorescence panel). Cytochrome C
was stained with a red fluorescent signal and when co-
localised with the mitochondrial fluorescent green signal,
showed yellow. However, in ANP-exposed cells, cyto-
chrome C is released from the mitochondria and this
can be observed in a clear pure red fluorescent signal,
indicating loss of mitochondrial integrity and apoptosis
(arrows on the right ANP column in Fig. 5). Unlike TT1
cells, all NPs induced ROS production in AT2 cells,
however only ANPs induced mitochondrial swelling and
loss of mitochondrial membrane integrity, as seen by
TEM (Fig. 4k), and breakdown of the mitochondrial
network (Fig. 5). This was associated with the release
of cytochrome C (Cyt C indicated with arrow) within
the cells, though this was not as noticeable as that
observed in TT1 cells (Fig. 5). Again, all types of NPs
induced ROS in MACs; interestingly, unlike the epi-
thelial cells, in MACs, both CNPs and ANPs initiated
mitochondrial swelling (Fig. 4–5); however, breakdownFig. 3 Effect of polystyrene nanoparticles on total cellular glutathione and
GSH) at 1 and 4 h exposure. GSSG:GSH ratio following exposure to 50 nm
Total GSH following exposure to 50 nm (c) and 100 nm (f) for 4 h with and
most significant increases in GSSG:GSH ratio, regardless of particle size. All t
most marked following ANP exposure (c, f). NAC treatment significantly preof the mitochondrial network and release of Cyt C
could only be observed in MACs exposed to ANPs
(see arrows in Fig. 5).
Uptake of nanoparticles by TT1, AT2 and MAC
TEM and scanning electron microscopy (SEM) were
employed to observe nanoparticle-cell interactions and
particle uptake (Fig. 6, 7 and 8). We recently showed
that the uptake and transport of the same set of latex
nanoparticles (t = 4 h) through TT1 cells involved both
passive and active transport depending on their size and
surface chemistry [16]. The 50 nm NPs largely entered
TT1 cells via passive transport, while the 100 nm NPs
entered mainly via clathrin- and caveolin-mediated
endocytosis; 50 nm ANPs were internalised more rapidly
than the UNPs and CNPs [16]. 3−8 % of 50 nm UNP
and CNP translocated across the TT1 monolayer, with-
out interfering with TT1 monolayer integrity [16]. It was
demonstrated that the NPs can traverse between TT1
cells, until they reach a tight junction [16], also shown
here in Fig. 7h and which suggests that the integrity of
the tight junction (white tj, arrow), and its location, con-
trols the translocation of these NPs between epithelial
cells. The aim of the study did not include the effect of
NPs on cell monolayer integrity and their translocation;
however, work on the TT1 cell in this respect isTT1 cellular oxidised glutathione: reduced glutathione ratio (GSSG:
(a, b) and 100 nm (d, e) NPs for 1 (a, d) and 4 h (b, e) respectively.
without antioxidant N-acetylcysteine (NAC, 10 mM). ANPs caused the
hree NPs caused a reduction in total cellular GSH, though this was
vented this effect (c, f). *p < 0.05, p** < 0.001; n = 3 replicates
Fig. 4 Effect of 50 nm polystyrene nanoparticles on mitochondrial membrane potential (a-c) and structure (d-o) following 4 h exposure. ANPs
caused a significant reduction in the mitochondrial membrane potential (**p < 0.001, n = 3 TT1 replicates and 6 subject samples for AT2 and
MAC) of all cell types (a-c) and altered mitochondrial structures by causing mitochondrial swelling (arrows in g, k, o) compared with the control
(d, h, l). There was only slight mitochondrial swelling in MACs following CNP exposure (arrows n) not seen following UNP exposure (m). The
number of total observed cells analysed/sample was 60 (n = 60); scale bar 500nm
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were exposed to 50 μg/ml NPs, as this concentration
exhibited very low toxicity (viability was 92−95 %,
Additional file 1: Figure S1, [31]) at 4 h exposure and
was a critical concentration at which a change in mito-
chondrial structure was observed. 40−60 % of TT1 cells
and 50−70 % of MACs internalised NPs, whereas only7−22 % of AT2 cells contained NPs (Fig. 6m-o). Inter-
estingly, there was little difference between NP-
functionalisation and the number of NPs taken up by
each cell type, despite marked differences in cell
viability, where ANP were most cytotoxic. Neither was
there any difference between the particle sizes. This indi-
cates that surface charge is an important component of the
Fig. 5 Effect of polystyrene nanoparticles on cytochrome C (Cyt C) release and the mitochondrial network (Mito) in TT1, AT2 and MAC.
Exposure to 50 μg/ml 50 nm UNP and CNP had no effect on the release of Cyt C or the mitochondrial network. ANP caused disruption
of the mitochondrial network (arrows indicate breakdown of Mitochondria in green) and initiated the release of Cyt C (arrows indicate
the red area of Cyt C release) in all cell types). Cell nuclei, mitochondrial networks and cytochrome C are stained blue, green and red,
respectively; n = 45 cells analysed/sample
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where 100 nm ANP-functionalised NPs caused relatively
little cytotoxicity. The uptake of NPs by AT2 cells was
much lower than that of the TT1 cells and the number of
cytosolic NPs in AT2 cells was also much lower than that
of the TT1 cells (data not shown). TT1 cells internalised all
types of NPs following 4 h exposure (Fig. 6b-d, m, Fig. 7).
The 50 nm and 100 nm NPs were observed within TT1 cell
vesicles, suggesting active uptake (Fig. 6c-d, Fig. 7). Particlesin endo/lysosomal compartments of TT1 were in the form
of agglomerates, possibly aggregates (Fig. 6b-d). Cytoplas-
mic NPs were present as individual particles (Fig. 6b, c, l
and Fig. 7c-e and k), suggesting passive uptake of NPs or
that NPs might escape from endo/lysosomes. Use of the
LysoTracker® fluorescent probe indicated an effect of NPs
on lysosomal membrane integrity. The decrease in mean
fluorescence intensity (MFI) of the probe indicated a de-
crease in the number of intact lysosomes within the cells
Fig. 6 Transmission electron micrographs of TT1, AT2 and MAC following exposure to 50 nm UNP, CNP and ANP for 4 h. The data are presented
as TEM images (a-l) and quantitatively as bar graphs (m-o). Following exposure to 50 μg/ml 50 nm NPs, TT1 and MAC internalised all three types
of NPs, (m, o, arrows in b, c, d, j, k, l), whereas much lower numbers of AT2 cells internalised NPs (n). UNP and CNP were observed adhering to
AT2 cell membranes (arrows in f-g). Once internalised, all types of NPs were observed mainly in endosomal structures. Percentage cell uptake is
presented in m-o (*p < 0.05, **p < 0.001, n = 3, total 90 cells analysed). The reduction in mean fluorescence intensity (MFI) of Lysotracker® probe
(p) indicates the lysosomal disruption following 4 h exposure of TT1 cells to ANPs (**p < 0.001, n = 3)
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caused a significant reduction in the MFI of LysoTracker®
(p < 0.001, n = 3, Fig. 6p) suggesting that the amine-surface
modified NPs precipitated lysosomal membrane damage
and, subsequently, escaped to the cytoplasm possibly via a
‘proton sponge’ mechanism [36]. We previously reported
that ANPs caused pore formation in the cell membrane
which may be one mechanism of passive uptake of 50 nmANPs [31]. In addition, NPs (Fig. 7c and k) appeared to ad-
here to the TT1 cell membrane and penetrate into the cell
cytoplasm. The uptake of individual particles was also ob-
served to occur at the lateral, paracellular and cell-cell
interface, where NPs had tracked between the cells, up to
the tight junction, before translocation as individual NPs
across the cell membrane (Fig. 7 d-e and h-i) as we previ-
ously reported [16]. It is difficult to assess whether particles
Fig. 7 Interaction and uptake of 100 nm polystyrene UNP. CNP and ANP by TT1 cells 4 h after exposure. Following exposure to 50 μg/ml NPs,
compared to non-exposed TT1 cells (a), UNPs were taken up via endocytosis as an agglomerate (arrows in b) and as individual particles (arrows
in c). UNPs were also observed paracellularly and were taken up individually (arrows in d-e). Similar observations were made following TT1 cell
exposure to CNPs (f; arrows in g indicate endocytosis and macropinocytosis). The CNPs also travelled paracellularly (left arrow in h, right arrow
indicates tight junction-tj). The ANPs were taken up via endocytosis as agglomerates (arrows in j) and individually (arrows in k), but few were
observed paracellularly. The percent cell uptake of all NPs by all cell types is shown in Fig. 6m-o in comparison with the 50 nm NPs. Scale bars in
a-k are 200 nm; a total of 90 cells were examined
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We used a sample preparation and staining technique, with
osmium, uranyl acetate and lead citrate post-stain, to spe-
cifically identify membranes and believe that any mem-
branes, including vesicular membranes should have been
apparent. Thus, we believe that some particles appear to be
free within the cytosol. And, importantly, this latter, para-
cellular process was less obvious with ANP suggesting dif-
ferent uptake mechanisms (Fig. 7j-k). In contrast to TT1
cells, most of which internalised all types of 50 nm NPs,
only a small proportion of AT2 cells (6−20 % from Fig. 6,
[16, 29]) were found to contain NPs (Fig. 6f-g, n). Intracel-
lular ANPs were only found in the endosomal compart-
ment (Fig. 6h), indicating active uptake.
To observe how NPs interact at the cell surface, we
used scanning electron microscopy (SEM, Fig. 8) to ob-
serve the cell-nanoparticle interface. We previously re-
ported that latex NP could initiate the protruding of
microvilli in live cell experiments of TT1 interactions
[31, 37] using scanning ion conductance microscopy
[31]. A similar effect was observed here with AT2
(Fig. 8); the presence of all types of 50 nm NPs, 50 μg/
ml, induced microvilli formation, possibly modifying NP
interaction with AT2 cells, as the microvilli protruded
and surrounded the NPs (Fig. 8a-d; [31]). Both agglom-
erated and individual NPs adhered to the cell membrane,amongst the cell surface microvilli, which were more
dense and co-localised with the NPs (Fig. 8d, f and h).
All types of 50 nm NPs were detected within the vesicle
compartments of MACs, as agglomerates, suggesting
phagocytic uptake (Fig. 6k, o). SEM indicated altered
MAC morphology after exposure to NPs (Fig. 8i-o).
UNP-induced changes in MAC morphology were of the
classic activated macrophage, exhibiting extensive filo-
podia (Fig. 8j-k); in contrast, MACs exposed to CNP and
ANP were devoid of filopodia and showed blebbing of
the cell membrane (Fig. 8l-o), possibly prior to apoptotic
cell death. All three NPs were found adhered to the cell
membrane of MACs (Fig. 8k, m, o).
Discussion
In this study, the response of human pulmonary alveolar
epithelial cells and alveolar macrophages to NPs of dif-
ferent size (50 and 100 nm diameter) and surface modi-
fication (UNP, ANP and CNP, Table 1) were examined.
Both size and surface charge are crucially important de-
terminants of alveolar cell responses. In addition, the
striking differences between cell types in their interac-
tions with, and reactions to, nanoparticle exposure, are
likely reflecting their functional role within the alveolus.
The ability of polystyrene latex NPs to induce cell
death, cellular oxidative stress and oxidative damage
Fig. 8 Interaction of UNP, CNP and ANP with the cell surface membrane of AT2 cells and MAC. AT2 cells exposed for 4 h to 50 μg/ml of 50 nm
polystyrene UNP (c-d), CNP (e-f) and ANP (g-h) compared to the non-treated control AT2 (a-b). Both individual and aggregated forms of all types
of NPs were observed on the cell surface membrane of AT2 cells, situated amongst microvilli (arrows in d, f, h; n = 60 cell observations). Scanning
electron micrographs of control MAC (i) and MAC exposed to 50 μg/ml of 50 nm polystyrene UNP (j-k), CNP (l-m) and ANP (n-o) for 4 h. MACs
were activated following exposure to UNP (j-k), CNP (l-m) and ANP (n-o). Both individual and aggregated forms of NPs were observed on the cell
membrane of MACs (arrows in k, m, o). UNP triggered filopodia formation, while CNP and ANP initiated membrane blebbing. All type of NPs
were observed in association with cell surface microvilli
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of all types of NPs in tissue culture medium DCCM1
indicated that these particles bind to proteins in the
medium, mostly albumin, as described elsewhere [30,
31]. Thus the surface charge changed (zeta values) to be
between −11 and -15 mV showing less difference be-
tween the different NP surface charges. Nevertheless,
there were significant differences in the bioreactivity of
these particles between the different cell types. One rea-
son for this may be that albumin forms a soft corona
that is easily displaced and, on interaction with specific
components of the cell membrane [38, 31], the particles
then exhibit their original surface chemistry. Although,
the RPMI did not contain serum and protein, the aggre-
gation or agglomeration of NPs could be observed with
100 nm NPs (all types) and 50 nm ANPs with zeta
values between −16 and -27 mV. This suggested that salt
and amino acids within RPMI could be involved in the
aggregation or agglomeration. Interestingly, however,
when IL-6 and IL-8 release (Additional file 1: Figure S5–
S6) was examined in AT2 cells, the response was the
same for all three particles, despite their surface chemis-
try. We recently showed that these NPs adsorb SP-D
from human lung secretions [39], and we know that in
this human AT2 cell model, surfactant is released [30].
We suggest that in this case, the albumin has been dis-
placed by components of surfactant or other AT2 cell
secretions that then triggers an identical response in the
AT2 cells. We appreciate that it might be possible to
avoid the effects of albumin adsorption from the
medium by using air-liquid interface cultures and aero-
solised particles [40]. Despite this, in this study we have
shown markedly different responses between cells of the
alveolar unit when challenged with NPs with different
surface chemistry which we believe are important, and
which we intend to study at an air liquid interface in
future.
Nevertheless, the original surface charge of the poly-
styrene NPs was extremely important in their bioreactiv-
ity. As we and others have shown previously [16, 31, 41],
amine-modified NPs are particularly cytotoxic at high
concentrations [16, 17]. Even at lower, non-cytotoxic
concentrations, 50 nm ANPs induced significant oxida-
tive stress in all three cell types over a period of 24 h.
Although UNP and CNP did not induce significant cell
death, both these particles induced a high ROS response
in AT2, similar to that observed following ANP exposure
(Fig. 2; Additional file 1: Figure S7), but less so in TT1
cells, illustrating that induction of ROS varies according
to the target cell. Addition of NAC significantly (p <
0.01, n = 3(TT1), 6(AT2)) reduced ROS production in
TT1 and AT2 cells. MAC produced the lowest ROS
levels both at baseline and following NP, likely due to
the lower cell density of MACs compared to the TT1and AT2 cells (Fig. 2). Therefore cells situated adjacently
in situ responded quite differently to the same stimulus;
furthermore, high ROS is not always linked to cell death.
By using two types of dye tracking ROS, we found that
ROS production by TT1 cells involved peroxide, singlet
oxygen and superoxide (as both dyes exhibited a similar
trend) whereas the ROS produced by AT2 and MAC
was mainly superoxide. These findings indicate different
oxidative stress processes between the cell types. The
role of cationic NPs in induction of oxidative stress has
previously been observed [17, 42, 43], using a variety of
cell lines, both immune and structural cells. Induction of
oxidative stress in a macrophage cell line by amine-
modified NPs [17], amine-modified silicon nanoparticles
(SiNP-NH2), resulted in cell death accompanied by ROS
production [43] which was not observed with neutral
and anionic silica nanoparticles. A similar phenomenon
was described for the RAW 264.7, phagocytic cell line,
exposed to amine-modified polystyrene nanoparticles
[17], which lead to apoptotic cell death, in contrast to
that in BEAS2-B cells, which exhibited necrotic cell
death. However, in another study using cationic and an-
ionic CdSe quantum dots [43], the cationic particles
conferred the most toxicity against primary human air-
way epithelial cells, but this did not parallel ROS induc-
tion [44].
Increased TT1 cell ROS activation was accompanied
by a reduction in total cellular glutathione and an in-
crease in the ratio of oxidised glutathione to reduced
glutathione (GSSG:GSH; Fig. 2, 3), particularly on expos-
ure to 50 nm ANPs, accompanied by cell death, suggest-
ing that increased ROS was the cause of cell death.
Comparing the 50 and 100 nm NPs, the 50 nm NPs ini-
tiated a faster and higher ratio of [GSSG]: [GSH] which
peaked at t = 30 min following exposure (data not
shown), before falling at t = 1 h (Fig. 3); this then in-
creased after 2 h exposure, peaking at 4 h (Fig. 3). A
slower response was observed with TT1 cell exposed to
100 nm NPs which showed no effect at 30 min following
NP exposure (data not shown) before the [GSSG]:
[GSH] was increased markedly for all NPs at 1 h, above
that for the 50 nm NPs, but which then fell for UNP
and CNP, but for ANP peaked at t = 4 h exposure. This
suggests a dynamic flux of [GSSG]:[GSH] which is tem-
poral and related to particle size and charge. However,
NAC treatment reduced oxidative stress but did not
markedly ameliorate 50 nm ANP-induced TT1 cell
death, again suggesting that induction of ROS is not al-
ways responsible for cell death. An intriguing discovery
was that co-application of NAC could significantly re-
duce or prevent polystyrene-induced ROS production in
epithelial cells, but had much less effect on ROS produc-
tion by MACs (Fig. 2). This may be due to the low base-
line of ROS production in MACs exposed to NPs,
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sensitivity; a significant protective effect of NAC was
only observed with MACs exposed to ANP (p < 0.05,
n = 3). Xia et al. [17] reported that NAC could not pro-
tect RAW264.7 exposed to amine-modified polystyrene
latex at 8 h, but this protective effect was re-observed at
16 h indicating time dependent process. NAC may pro-
tect cells because: i) NAC is a free radical scavenger and
precursor of GSH and would be expected to protect
GSH as well as replenish used GSH or supplement exist-
ing GSH; ii) NAC might also activate anti-apoptotic
signal transduction pathways involved in cell survival
[45, 46]. The inability to prevent polystyrene NP-
induced ROS in MACs using NAC suggests that either
the depletion of GSH was greater than that provided by
supplementary NAC treatment, and/or that an alterna-
tive process is causing ROS production.
Nevertheless, ROS markedly increased in AT2 and
MAC following exposure to all types of NPs indicating
that induction of ROS was an important consequence of
NP exposure, but supporting the proposal that other
mechanisms are involved in cell death, which was largely
a feature of ANP exposure. Previous studies indicate that
early mitochondrial injury is an important feature of
amine-modified polystyrene NP-induced cell death [42],
where mitochondrial integrity and structure were af-
fected. Thus, in a comparative study of the effects of
amine-modified, 60 nm polystyrene particles on RAW
264.7 and BEAS2-B cell lines, the mitochondria were
identified to be a target but the cellular reaction differed.
Mitochondria in RAW 264.7 cells were swollen and
lacked cristae exhibiting apoptotic cell death. In contrast,
in BEAS2-B cells, the mitochondria were condensed and
eventually disappeared exhibiting necrotic cell death.
These differences between cellular responses to the same
amine-modified nanoparticles were attributed to alterna-
tive modes of nanoparticle uptake, fate and bioreactivity
within the cell. Mitochondria are considered to be the
most important organelles in producing ROS and are
also the first targets for ROS. It is possible that overpro-
duction of ROS might damage the structure of
mitochondria, triggering cell death via mitochondrial
uncoupling and the release of cytochrome C and other
apoptotic factors [47]. Indeed, in all three cell types,
50 nm ANP induced ROS, the swelling and breakdown
of the mitochondrial network, and release of cytochrome
C (Figs. 2, 4, 5), an important component of the apop-
totic pathway. These findings are consistent with the
increase in ROS and GSSG/GSH ratio in TT1 cells ex-
posed to ANPs. This also corresponds with our previous
observation that ANP exposure induced the release of
TT1 cell caspase 9 and 3/7 suggesting that induction of
the intrinsic apoptotic pathway is the major mechanism
of ANP-induced TT1 cell cytotoxicity [31]. From ourprevious findings and this study, we have proposed a
pathway of ANP-induced TT1 toxicity. Based on the
findings in this study we suggest that this process may
be applied with AT2 cells and MACs. However, we also
observed LDH release, suggesting necrotic cell death,
but which might have been due to secondary necrosis of
apoptotic cells in the absence of efferocytosis and clear-
ance of apoptotic cells. In contrast to these observations
with ANPs, although UNP and CNP triggered increased
ROS, notably in AT2 and MAC, this did not impact on
mitochondrial integrity or cell viability, indicating the
significance of surface chemistry in cellular bioreactivity.
As mentioned earlier, the cellular response to amine-
modified particles is also believed to relate to cellular
uptake mechanisms and quantity of particles internalised
[35, 45–47]. Here, we studied the NP uptake of TT1 and
another two cells types (AT2 and MACs) using TEM, an
accurate but time consuming technique to quantify the
percent of NP uptake. We previously employed other
rapid techniques including flow cytometry, confocal mi-
croscopy, transwell plate studies to quantify particle up-
take and transport across TT1 cells [16]. Our findings
adds more information on NP uptake and help to
complete the picture. All types of NPs were found in a
high proportion of TT1 and MACs, whereas in AT2,
only ANP were observed in a very low proportion of
cells. One mechanism by which TT1 cells internalise
molecules is by endocytosis, which may lead to transfer
of molecules across the alveolar gas-blood barrier, via
caveolae and clathrin coated vesicles [48, 49, 16]; the
presence of 50 and 100 nm NPs in TT1 cells, as small
and large agglomerates within endosomal vesicles, re-
flects this and suggests that another mechanism involves
macropinocytosis. Cytoplasmic, individualised CNP and
UNP could be due to passive uptake of the individual
NPs (Fig. 7); these NPs may penetrate intracellular cell
membranes or they might passively diffuse through cell
membranes, without involving cellular energy. However,
TEM cannot indicate whether the NPs are fusing with
the phospholipid membrane or whether they are at-
tached to it. Further investigation using high resolution
TEM would be useful to establish this. Despite internal-
isation by TT1 cells, CNP and UNP were not overtly
toxic. ANP were taken up apically by TT1 cells; cyto-
plasmic ANPs may reflect transfer via cell membrane
pore formation, as demonstrated by us and others pre-
viously [31, 50]. We hypothesise that, at high concentra-
tions, excessive membrane damage could cause cytotoxicity
[51, 52]. Alternatively, release of ANPs due to endosomal
rupture could occur [53, 54]; cytosolic ANPs in TT1 could
initiate cell death, as suggested previously [31, 42].
Other studies describe the impact of cationic nanoparticle
surface modification on uptake, which is consequently be-
ing used as a drug targeting strategy; cationic surface
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co-glycolide)/lipid-based nanoparticles, silica-titania hollow
nanoparticles, iron nanoparticles, latex nanoparticles and
megitoliposomes, enhanced their uptake by a wide range of
cell lines [55–59]. However, endosomal and passive uptake
of cationic nanoparticles may account for the observed
toxicity of these particles, as described here, and elsewhere
[17, 42]. A high density of amino surface groups on the
surface of ANPs may trigger escape from endosomes and
phagosomes by the so called ‘proton sponge’ phenomenon
[37, 53, 54]. This could enhance the possibility of a direct
interaction between ANPs and cell organelles, resulting in
cell death. In contrast, for carboxyl-modified polystyrene
nanoparticles, Fröhlich et al. [60] report that endosomal/
lysosomal 20 nm carboxyl-modified nanoparticles within
EAhy926 endothelial cell lines caused alteration of lyso-
somal enzyme activity but did not cause any lysosomal
swelling and disruption. Such processes could explain the
differences in cytotoxicity of neutral, cationic and anionic
polystyrene in the present study. Thus, lysosomal disrup-
tion and release of potent lysosomal enzymes could con-
tribute to ANP-induced cell death, as these enzymes have
been shown to activate apoptotic cell death pathways, for
example via direct damage to the mitochondria and pro-
teolytic activation/inhibition of cellular processes.
Conclusion
In this study of the response of three human cells that
constitute the alveolar unit to 50 nm and 100 nm NPs,
we have shown marked differences in the cellular re-
sponses depending on size and surface chemistry of
NPs, and also on the type of cells. An important finding
was that amine functionalization caused cytotoxicity in
all three cell types, involving a process of induction of
oxidative stress, mitochondrial disruption and Cyt C re-
lease, and likely leading to apoptotic cell death. Most of
epithelial type 1 cells and macrophages internalised
ANPs reflecting their functions in translocation of bio-
molecules across the gas–liquid interface and removal of
organic and inorganic material from the alveoli, respect-
ively. This implies that particle uptake is a pre-requisite
to cell death, however, most AT2, largely secretory cells,
showed much lower ANP internalisation, and yet ANPs
were cytotoxic, indicating that there might be alternative
cell surface-dependent mechanisms of cellular signalling
that trigger oxidative stress and cytotoxicity. On the
other hand, if cell death requires ANP uptake, followed
by rapid death of the AT2 cells which contain the ANP,
and survival of those that do not take up ANP (cell via-
bility 70−80 % at ANP concentration of 50 μg/ml), this
would confound the use of electron microscopy to relate
ANP uptake to AT2 cell death because the dynamic re-
sponse at cell-nanoparticle interface was observed. Fur-
ther studies are required. Importantly, UNP and CNPdid not induce marked cell death even though they were
internalised by TT1 cells and MACs, and they induced
ROS, mostly in AT2 cells and MACs. This suggests that
the focus on induction of oxidative stress as a marker of
cytotoxicity and therefore increased hazard to inhaled
nanomaterials does not reflect the import of raised oxi-
dative stress in protection from such challenges. Thus,
NP uptake does not automatically relate to cytotoxicity,
although induction of ROS suggests that other cellular
processes might be harnessed. In vivo, the epithelial li-
quid lining layer contains significant concentrations of
non-enzymatic antioxidants, which this study of NAC
suggests would protect alveolar epithelial cells from NP-
induced ROS. Type 1 cells cover 95 % of the alveolar
surface and this unique study indicates that these cells
are most robust in the presence of neutral and carboxyl-
modified nanoparticles, which enter the cells. We sug-
gest that type 1 cells provide an excellent target for
inhaled NP drug delivery systems, both with the lung as
a target, and for systemic delivery, being in close appos-
ition to the microvasculature.
Methods
Culture of human immortalized alveolar epithelial type 1
cells (TT1)
The immortal TT1 cells were created from primary hu-
man alveolar epithelial type 2 cells isolated from the
healthy region of tissues as previously described [29]
which shows the same characteristics and phenotype as
AT1 in vivo [29]. The TT1 cells were routinely grown in
defined cell culture medium (DCCM1, Cadama, UK)
supplemented with 10 % new-born calf serum (NCS)
and 1 % penicillin/streptomycin/l-glutamine (PSG). They
were seeded at a density of 0.5x106 cells/well in 24-well
plates until they reached confluence, within 2 days. 24 h
prior to NP exposure, the cells were serum starved.
Isolation of primary human alveolar macrophages (MAC)
The tissues used in this study were surplus tissue ob-
tained following resection for lung carcinoma and writ-
ten informed consent was obtained for all samples. The
study was carried out with the approval of the Royal
Brompton and Harefield Ethical Committee (Ref: 08/
H0708/73). MAC were isolated from lung tissue as pre-
viously described [61]. Cells were isolated from a mini-
mum of six different donors per experiment (n = 6). The
lung tissues were perfused with 0.15 M sterile sodium
chloride solution until the draining lavage became clear.
The perfused saline was collected into 50 ml conical
Falcon tubes and centrifuged at 1300 rpm (rotor radius
is 168 mm) for 10 min at 20 °C. The cell pellet was
re-suspended in serum-free RPMI culture medium sup-
plemented with 1 % penicillin/streptomycin/l-glutamine
(PSG) and plated onto 96 well culture plates at 0.2 × 106
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oxidative stress and uptake studies). These MACs settle
down and adhere to the plate within 3 h of seeding. The
medium was removed and the cells were was carefully
rinsed with phosphate buffer solution (PBS) to remove the
non-adherence cells. The cells were maintained in serum-
free RPMI medium (0 % serum in RPMI) supplemented
with 1 % PSG and incubated in 5 % CO2 at 37 °C.
Isolation of primary human alveolar epithelial type 2 cells
(AT2)
The tissue remaining following the MAC isolation was
then used for AT2 cell isolation as previously described
by Witherden et al. [62]. Cells were isolated from a
minimum of six different subjects per experiment (n =
6). Cells were suspended in DCCM1 medium (Cadama,
UK) supplemented with 10 % NCS and 1 % PSG and
they were seeded on 96 well culture plates at 0.1 × 106
cells/well (and 0.5x105 cells/well in 12-well plate for
oxidative stress and uptake studies). The wells were
pre-coated with 1 % type I collagen solution (PureCol,
Netherlands). Cells reached confluence 48 h after seed-
ing, they were thoroughly characterised using electron
microscopy illustrating their cuboidal morphology, la-
mellar bodies, tight junctions and microvilli [30, 62].
They were also stained positively for the AT2 cell
marker alkaline phosphatase and expressed surfactant
proteins A and C. Their retained the AT2 cell phenotype
for up to 6 days [30, 62] and were used in these studies
within three days of seeding. After reaching confluence,
the cells were serum starved for 24 h before the
exposure.
Particle size and zeta potential
The 50 nm and 100 nm latex polystyrene nanoparticles
(NPs), unmodified, carboxyl and amine-modified were
purchased from Sigma Aldridge, UK. NPs were sus-
pended in distilled water (DW) and DCCM1 culture
medium without serum, (Cadama, UK) at a final concen-
trations of 10 mg/ml. NPs were vortexed and filtered
through a 0.22 μm (50 nm NPs)/0.45 μm (100 nm)
membrane filter. The samples were sonicated in a sonic-
ation water bath for 2 min just prior to measuring size
and zeta potential using a Zetasizer Nano (Malvern In-
struments Ltd, UK).
Exposure of cells to NPs
MACs and TT1 cells were routinely seeded and cultured
into each well of a 96-well or 24-well plates, in RPMI
1640 serum-free medium (MACs) and DCCM1 (TT1),
10 % new born calf serum (NCS), and 1 % PSG, respect-
ively. AT2 cells were seeded at the same density on the
collagen coated plate as described above. At confluence,
24 h prior to NP exposure, the medium of TT1 and AT2was replaced with serum-free DCCM1. For MACs the
cells were washed twice time to remove non-adhering
cells and red blood cells before the exposure. The cells
were exposed to 0–100 μg/ml (0–50 μg/cm2) NP for 4
and 24 h at 37 °C with or without N-acetyl cysteine
(NAC), 10 mM, in serum free medium.
Cell viability (MTT assay)
Following the 24-h exposure period, the medium was re-
moved, the cells were thoroughly washed with PBS to
remove residual NPs and then incubated with 3-(4, 5-
Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) in fresh medium, 50 mg/ml, for 2.5 h at 37 °C.
The medium was removed and 200 μl of DMSO was
added to each well to dissolve the cells and the insoluble
formazan dye. The plate was placed on a rotary shaker
briefly and centrifuged at 14,000 g for 20 min to remove
any residual NPs, before reading the optical density of
the supernatants using a Thermomax microplate reader
at 570 nm (MTX Lab Systems, USA). The viability of
the cells exposed to NPs was then calculated as a per-
centage of the non-treated control cells (exposed to
PBS). To determine the effect of NPs on the MTT assay,
NPs were: (i) added to unexposed, control cells immedi-
ately before the assay, or (ii) added to the assay system
following DMSO dissolution, and then processed identi-
cally to cellular experimental cells. The assay solutions
were centrifuged at 14,000 g to remove the NPs from
suspension prior to determination of the optical density
of the supernatant, to avoid interference in optical dens-
ity readings by NPs; experiments were carried out in
triplicate for TT1 cells (n = 3) and n = 6 for the AT2 cells
and MAC.
Lactate dehydrogenase assay (LDH)
After 4-h and 24-h exposure periods, the conditioned
medium was collected and centrifuged at 14,000 g for
20 min to remove the cell debris and residual NPs. LDH
was analysed using the Cytotoxicity Detection kit PLUS
(LDH; Roche, UK). For the positive control (100 % LDH
release), 2 μl of cell lysis reagent (provided with the kit)
was added into medium of non-treated cells and the
cells were further incubated for 15 min before the
medium, containing the LDH released from the lysed
cells, was collected for centrifugation and LDH assay
performed following the manufacturer’s protocol. 50 μl
of the substrate (provided with the kit) was added to
50 μl of sample medium and the plates were incubated
for 45 min before the stop solution was added. For the
control and the substance control, a known concentra-
tion of LDH standard (0.05 U/ml) was incubated with a
sample of DCCM1 medium, with or without increasing
concentrations of the NPs and the assay performed in an
identical manner. The data were collected by reading
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momax microplate reader (MTX Lab Systems, USA).
There was no significant interference by the NPs because
they were removed by centrifugation prior to reading the
optical absorption, as described above. Three replicate ex-
periments were performed for TT1 and six replicate experi-
ments were performed for AT2 and MAC.
Assessment of inflammatory mediator (IL-6 and IL-8) release
The release of inflammatory mediators interleukin 6 and
8 (IL-6 and IL-8) into the exposure media were mea-
sured using sandwich enzyme-linked immunosorbent
assays (ELISA). The assays were performed using
DuoSet® antibody kits (R&D systems, USA) following the
manufacturer’s protocol. The potential nanoparticle
interference was determined by adding NPs, 0–50 μg/
ml, into standard solution of IL-6 or IL-8 before the
ELISA was performed. No significant interference
(p > 0.001, n = 3) was observed between the normal
standard and the NP-addition standard suggesting that
the NPs did not interfere with the ELISA assay. The data
were collected by reading optical absorption at wavelength
of 450 nm using a Thermomax microplate reader (MTX
Lab Systems, USA). Six replicate experiments were carried
out using cells isolated from six different donors.
Reactive oxygen species (ROS)
Intracellular oxidative stress in cells was detected by im-
aging the fluorescence probes resulting from oxidation
of dihydroethidium (DHE) or 2′, 7′-dichlorodihydro-
fluorescein diacetate (H2-DCFDA). The H2-DCFDA is a
permeable compound which only detects intracellular
ROS. DHE is a readily permeable fluorescent dye which
can be oxidized by ROS, primarily superoxide, to yield
ethidium molecules. Ethidium subsequently binds to
DNA, which produces a detectable red fluorescence sig-
nal. After the exposure cells were washed twice with
warm PBS and incubated with 200 μl of 10 μM DHE or
5 μM H2-DCFDA (both from Invitrogen, UK) in serum-
free medium for 20 min. At the end of H2-DCFDA or
DHE incubation, cells were washed twice to remove
extracellular probe. The cells were imaged using Leica
SP2 inverted fluorescent microscopy (Germany) using
optical zoom ×10 and ×20. During imaging, the cells
were maintained with 5 % CO2 and 95 % O2 in the live
cell imaging chamber with heated base setting at 37 °C.
The mean fluorescent intensity (MFI) of the H2DCFDA
(ex488/em512nm) and DHE (ex535/610 nm) in the im-
ages was quantified using ImageJ (FIJI). Experiments
were performed in triplicate.
Glutathione assay (GSH)
Cellular antioxidant glutathione (GSH) was analysed using
GSH/GSSH ratio assay kit (Calbiochem, Merckbioscience,UK) following the manufacturer’s protocol. Briefly, after the
exposure cells were collected by centrifugation at 2000xg
for 10 min at 4 °C. The cell pellet was sonicated in 1-2 ml
of cold PBS buffer for 10 min and the cell debris was re-
moved by centrifugation at 10,000xg for 15 min at 4 °C.
The supernatant was collected and deprotonated by adding
10 % metaphosphoric acid and centrifuged at 5000xg for
10 min at 4 °C. The supernatant was stored at −20 °C until
the assay was carried out. The optical absorbance at a
wavelength of 450 nm was determined using a Thermomax
microplate reader (MTX Lab Systems, USA). Experiments
were carried out in triplicate.
Monitoring mitochondrial pathology using MitoTracker®
Green FM
MitoTracker® Red FM is a readily permeable fluorescent
dye exhibiting potential-dependent accumulation in ac-
tive mitochondria within live cells. The loss of mito-
chondrial membrane potential inside the cells will cause
a reduction in the accumulation of the dye. Following
NP exposure, the cells were washed twice with PBS be-
fore they were incubated with 50nM of MitoTracker®
Red FM in RPMI medium for 45 min at 37 °C in 5 %
CO2. At the end of the incubation, cells were washed
twice with PBS to remove the excess probe before the
fluorescent intensity of each well was measured using
the Multi-detection multiplate reader SynergyTM HT
(BioTek® Instrument Inc., USA) at an excitation and
emission wavelength of 490 and 516 nm, respectively.
Three and six replicate experiments were carried out on
TT1 cells and AT2/MAC respectively.
Monitoring lysosomal integrity using Lysotracker Red
DND-99
The readily permeable probe, Lysotracker Red DND-99
(Invitrogen, UK), was used to monitor number of intact
lysosomes following 4 and 24-h treatment with NPs. Fol-
lowing NP exposure, the cells were rinsed with PBS
twice and incubated with RPMI culture medium con-
taining 50 nM of the Lysotracker Red DND-99 probe,
for 40 min. At the end of the incubation period, cells
were washed twice with PBS to remove the excess probe
and fluorescence intensity in each well was quantified
using the Multi-detection multiplate reader SynergyTM
HT (BioTek® Instrument Inc., USA) at excitation and
emission wavelength of 577 and 590 nm, respectively.
The experiments were performed in triplicate.
Confocal fluorescence microscopy
For fluorescence microscopy, following NP exposure the
cells were fixed with 3.5 % paraformaldehyde, and per-
meabilised with 0.1 % triton X-100 for 20 min. At least
20 cells were surveyed per one slide (n = 10) and three
separate experiments were performed (total n = 30).
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1 % BSA in PBS for 30 min before staining with Alexa
fluor® 555 anti-cytochrome C (1:100 in blocking buffer;
Invitrogen, UK), for 1 h. Cells were washed with PBS
and stained with the mouse monoclonal primary anti-
body to mitochondria (Abcam, UK; dilution 1:100 in
blocking solution) for 1 h. The cells were washed and
stained with Alexa fluor488 anti-mouse IgG secondary
antibody (1:100 in blocking buffer; BD Pharmingen, UK).
Cells were rinsed well and mounted onto the slides with
ProLong® Gold (Invitrogen) before they were visualised
using Leica SP5 inverted confocal microscopy (Leica,
Germany). Not less than 15 cells were observed in each
slide and three slides were prepared for each sample,
n = 45 cells (total observed).Transmission electron microscopy (TEM)
Following NP exposure, the cells were rinsed and fixed
with 2.5 % glutaraldehyde for 2 h and then rinsed with
sodium cacodylate buffer. The samples were post-fixed
in 1 % osmium tetroxide for 1 h and dehydrated (with
25, 50, 75 % and dry ethanol) before embedding into
resin (Araldite®) and microtomed into ultra-thin section
(50−120 nm thick). The obtained sections were stained
with 2 % uranyl acetate (w/v in ethanol) and lead citrate
before viewing under TEM. Samples were processed for
observation using TEM (Hitachi H7000 Nissei Sangyo
Co., Ltd, Japan).TEM particle uptake analysis
This technique was adopted from our previous study
[63]. Three embedded samples obtained from three rep-
licate experiments were prepared, and three sections
were cut from each embedded sample for viewing (total
9 viewing sections (grids) per one sample). At least 10
cells were randomly selected from one section for obser-
vation (total viewing 90 cells per sample). The percent
cell uptake which was calculated from the number of
particle-internalised cells against the number of total
cells in each embedded sample (30 cells/3 viewing sec-
tions), and the percent cell uptake was calculated from 3
replicate experiments (n = 3) to achieve the total number
of 90 observed cells (from 9 viewing sections).Observation of mitochondrial structure
Three embedded samples obtained from three depre-
cated experiments were prepared, and two sections were
cut from each embedded sample for viewing (total 6
viewing sections (grids) per one sample). At least 10 cells
were randomly selected from one viewing section, and
their mitochondrial structures were observed (total view-
ing n = 60 cells per sample).Scanning electron microscopy (SEM)
For SEM analysis, cells were seeded onto coverslips for
TT1 cells and MAC, and on collagen coated coverslips
for AT2 cells. After NP exposure, the cells were proc-
essed using glutaraldehyde fixative (2.5 %) for 2 h and
osmocated for 1 h. The coverslips were then critical
point dried by immersion in hexamethydisilazane
(HMD) before attaching to the stubs. The specimens
(n = 60; 20 cells were randomly recruited from three sep-
arate experiments) were coated with gold before being
visualised under Hitachi S4000 SEM microscopy (Nissei
Sanyo, Japan).
Statistical analysis
The data are presented as mean ± standard deviation (SD)
where three and six replicate experiments were performed.
The data were analysed by one-way and two-way analysis of
variance (ANOVA) with Post-hoc analysis (Bonferroni)
using GraphPad Prism 5 software. Differences were consi-
dered significant at *p < 0.05, **p < 0.001 and ***p < 0.0001.
The number of experiments have been described for each
assay above and as appropriate.
Additional file
Additional file 1: Figure S1. Viability of TT1, AT2 and MAC following
exposure to 50 nm NPs for 4 h. Low toxicity was observed in TT1 and
MAC exposed to high concentrations of ANPs at t = 4 h. At the low
concentrations of 1–25 μg/ml ANPs did not show significant toxicity in
any cell type. *p < 0.05, n = 3 replicates TT1, and 6 subject samples AT2
and MACs. Figure S2. Effect of adding the antioxidant N-acetyl cysteine
to the 50 nm nanoparticles on cell viability. TT1 (a-b), AT2 (c-d) and MAC
(e-f) were exposed to 50 μg/ml of 50 nm UNP (a, c and e) and CNP (b, d
and f). There was no cytotoxicity on exposure to the NPs, neither was
there a significant effect of NAC. n = 3 replicates TT1 and 6 subject
samples AT2 and MAC. Figure S3. Release of lactate dehydrogenase
following exposure of AT2 cells to 50 and 100 nm UNPs, CNPs and ANPs.
The data are expressed as percent of the total cellular LDH in the unexposed
control cells. The 50 nm NPs caused release of LDH which was significantly
increased relative to NP concentration on exposure to CNP and ANP (b-c;
**p< 0.001, n= 6 subject samples). Exposure to 100 nm UNP and CNP had no
effect on LDH release (d-e), whereas 100 nm ANP induced significant release
of LDH in a concentration dependent manner (f). The 50 nm ANP induced
the highest level of LDH release compared to all other NPs. C, **p< 0.001,
n= 6 subject samples. Figure S4. Release of lactate dehydrogenase following
exposure of MACs to 50 and 100 nm UNPs, CNPs and ANPs. There was
significant, NP concentration dependent release of LDH by MACs following
exposure to all 100 nm NPs (d-f), which was most significant following ANP
(f; **p< 0.001, n= 6 subject samples). Although all types of 50 nm NPs caused
some release of LDH, this was only significant for ANP (c); the response was
NP concentration dependent but did not reach the same level as that
following 100 ANP exposure (c, f; **p < 0.001, n = 6 subject samples).
Figure S5. Release of IL-6 and IL-8 following exposure of AT2 cells to
UNPs, CNPs and ANPs. Both 50 and 100 nm NPs caused significant release
of IL-6 and IL-8 (**p < 0.001, n = 6 subject samples), although not in a dose
dependent manner. There was no difference in level of the IL-6 release
between the different types of NPs. Figure S6. Release of IL-6 and IL-8
following exposure of MACs UNPs, CNPs and ANPs. Both 50 and 100 nm
NPs caused a significant, dose dependent increase in IL-6 and IL-8 release
from MACs (**p < 0.001, n = 6 subject samples). Although there was no
difference between 50 and 100 nm NP on IL-6 release (a-c), the 100 nm NPs
caused more IL-8 release than 50 nm NPs. d-f, **p < 0.001,
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TT1 and AT2 cells exposed to UNP, CNP and ANP. The data are shown as
images (a-r) and quantitatively as bar charts (s-u). ANP initiated ROS production
following 4 h exposure at concentrations of 25 μg/ml and above (b-d; s). ROS
activated by 50 μg/ml of ANPs remained significantly high at 24 h (f, t), CNP
took up to 24 h to initiate ROS production in TT1 cells (g; t), although this was
lower than that for ANP. UNPs initiated only a small, but significant degree of
TT1 cell ROS production at 24 h (h; t). All types of NPs caused increased AT2
cell ROS production in a concentration dependent manner (i-r; u). The
fluorescence intensity of ROS are quantified and presented as mean
fluorescence intensity (MFI ± SD) as shown in s-u. **p < 0.001, ***p <
0.0001, n = 3 replicate experiments for TT1 cells and 3 subject samples
for AT2 cells.
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